Human Vaccines and Immunotherapeutics: News

Mostrar otras versiones (1)

GSK`s Synflorix: Highly effective at preventing invasive pneumococcal disease Positive phase 1 interim results for killed whole-virus HIV vaccine Therapeutic HBV vaccine drives immune responses in liver New tuberculosis vaccine candidate to enter the clinic Novartis receives positive CHMP opinion fo...

Descripción completa

Detalles Bibliográficos
Autor principal: Riedmann, Eva M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
News, Policy and Profiles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667948/
https://www.ncbi.nlm.nih.gov/pubmed/23442582
http://dx.doi.org/10.4161/hv.23607
Descripción
Sumario:GSK`s Synflorix: Highly effective at preventing invasive pneumococcal disease Positive phase 1 interim results for killed whole-virus HIV vaccine Therapeutic HBV vaccine drives immune responses in liver New tuberculosis vaccine candidate to enter the clinic Novartis receives positive CHMP opinion for MenB vaccine Bexsero New research points way to faster flu vaccines New Meth vaccine shows promise in animals RTS,S malaria vaccine reduces malaria by approximately one-third in African infants

Ejemplares similares